Baillie Gifford & Co. Sells 79,268 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Baillie Gifford & Co. trimmed its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 25.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 235,469 shares of the biotechnology company's stock after selling 79,268 shares during the period. Baillie Gifford & Co. owned 0.31% of Axon Enterprise worth $69,284,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently made changes to their positions in AXON. International Assets Investment Management LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $39,907,000. Lindbrook Capital LLC grew its position in Axon Enterprise by 43.3% during the 4th quarter. Lindbrook Capital LLC now owns 172 shares of the biotechnology company's stock worth $44,000 after purchasing an additional 52 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd grew its position in Axon Enterprise by 21.9% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 6,978 shares of the biotechnology company's stock worth $1,803,000 after purchasing an additional 1,255 shares during the period. Handelsbanken Fonder AB grew its position in Axon Enterprise by 10.0% during the 4th quarter. Handelsbanken Fonder AB now owns 14,302 shares of the biotechnology company's stock worth $3,695,000 after purchasing an additional 1,300 shares during the period. Finally, GAMMA Investing LLC acquired a new stake in Axon Enterprise during the 4th quarter worth about $83,000. 79.08% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts have weighed in on AXON shares. Robert W. Baird increased their price target on Axon Enterprise from $355.00 to $360.00 and gave the stock an "outperform" rating in a research report on Wednesday, August 7th. Barclays increased their price target on Axon Enterprise from $381.00 to $387.00 and gave the stock an "overweight" rating in a research report on Wednesday, August 7th. Craig Hallum increased their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a "buy" rating in a research report on Wednesday, August 7th. Northland Securities increased their target price on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an "outperform" rating in a research note on Thursday, August 8th. Finally, JMP Securities reissued a "market outperform" rating and set a $375.00 target price on shares of Axon Enterprise in a research note on Wednesday, August 7th. Two analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. Based on data from MarketBeat, Axon Enterprise has a consensus rating of "Moderate Buy" and a consensus price target of $358.08.

Axon Enterprise Price Performance

Axon Enterprise stock traded down $1.99 during midday trading on Friday, reaching $370.70. The company had a trading volume of 464,467 shares, compared to its average volume of 522,665. The company has a market capitalization of $27.98 billion, a P/E ratio of 108.39, a P/E/G ratio of 10.01 and a beta of 0.95. Axon Enterprise, Inc. has a 12-month low of $189.12 and a 12-month high of $378.89. The firm's fifty day simple moving average is $318.22 and its 200-day simple moving average is $305.05. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.88 and a quick ratio of 2.52.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, beating analysts' consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million for the quarter, compared to analyst estimates of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. Axon Enterprise's quarterly revenue was up 34.5% compared to the same quarter last year. During the same period last year, the company posted $0.80 EPS. As a group, equities analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current year.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Matthew R. Mcbrady sold 2,000 shares of the stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the completion of the sale, the director now owns 4,892 shares in the company, valued at approximately $1,783,916.72. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $373.03, for a total transaction of $167,863.50. Following the completion of the sale, the director now owns 7,379 shares in the company, valued at approximately $2,752,588.37. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Matthew R. Mcbrady sold 2,000 shares of the firm's stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $364.66, for a total transaction of $729,320.00. Following the sale, the director now owns 4,892 shares of the company's stock, valued at approximately $1,783,916.72. The disclosure for this sale can be found here. In the last quarter, insiders sold 3,921 shares of company stock worth $1,313,659. Insiders own 6.10% of the company's stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.